Key Operational and Financial Highlights

The presentation provides a comprehensive business update and financial overview for Q1 FY27 (June 2026 quarter) and full-year FY26.

Q1 FY27 Consolidated Financial Performance (₹ in Crores):

  • Revenue from Operations: ₹440.3 crore, a 58.1% increase YoY (Q1 FY26: ₹278.5 crore) and a 16.4% increase QoQ (Q4 FY26: ₹378.1 crore)
  • Gross Margin: ₹34.2 crore, a 63.9% increase YoY
  • Gross Margin Percentage: 7.8% (Q1 FY26: 7.5%; Q4 FY26: 7.3%)
  • Employee Benefits Expense: ₹27.7 crore
  • Other Expenses: ₹21.4 crore
  • EBITDA: (₹14.9) crore; EBITDA %: (3.4%)
  • Other Income: ₹19.4 crore (includes financial service income)
  • Depreciation and Amortisation: ₹1.9 crore
  • Finance Costs: ₹0.6 crore
  • Profit After Tax (PAT): ₹2.0 crore; PAT %: 0.5%

Full Year FY26 Financial Performance (₹ in Crores):

  • Revenue from Operations: ₹1,305.9 crore, a 20.0% increase YoY (FY25: ₹1,088.1 crore)
  • Gross Margin: ₹97.5 crore; Gross Margin %: 7.5% (FY25: 6.5%)
  • EBITDA: (₹65.5) crore; EBITDA %: (5.0%)
  • PAT: (₹1.4) crore; PAT %: (0.1%)
  • EPS: ₹0.37

Revenue Breakup by Vertical (Q1 FY27):

  • Supply Chain (SastaSundar): ₹48.1 crore
  • RetailerShakti: ₹361.9 crore
  • Diagnostics: ₹0.7 crore
  • Healthcare Network Total: ₹410.7 crore
  • Financial Services: ₹49.0 crore
  • Total Revenue: ₹459.7 crore

Business Model and Strategy

The company describes itself as "India's AI-powered digital health platform" focused on making medicines, wellness, and diagnostics accessible. The core strategy is built on two philosophies:

1. Discipline: A Buffett-inspired focus on "real earnings" and capital efficiency, with a low-leverage model.

2. Patience: A Bezos-inspired approach of long-term reinvestment in technology, brand, and infrastructure.

The integrated platform encompasses consumer engagement, retailer enablement, direct manufacturer partnerships, automated fulfillment centers, and optimized logistics.

Operational Metrics and Capital Efficiency

Working Capital Management (Q1 FY27):

  • Net Working Capital Days: 28 days
  • Inventory Days: 39 days
  • Receivable Days: 3 days
  • Payable Days: 14 days
  • Working Capital as % of Revenue: 8% (₹128 crore)

Total Capital Deployed:

  • Total Capital Raised: ₹352 crore
  • Cost of Capital (post-tax) @9% p.a. XIRR: ₹431 crore
  • Net Capital after Buy Back: ₹683 crore
  • Capital deployed in IPR of Business: ₹122 crore

Market Positioning and Growth Levers

The presentation outlines several beliefs driving the business, including B2B distribution consolidation, the rise of distributor private-label brands, data-driven omnichannel experiences, AI-led behavior shifts, inclusive healthcare, and the growth of preventive care.

Geographic Footprint (Based on Sales Data):

  • Tier 1 (Urban Area): 33.1%
  • Tier 2 (Semi-Urban Area): 42.2%
  • Tier 3 (Rural Area): 24.8%

Order Value Analysis (Jan-Mar 2026 Data):

  • RetailerShakti (B2B): 42.4% of business from orders above ₹5,000, demonstrating a high-value, efficient B2B model.
  • SastaSundar (B2C): 69.2% of orders exceed ₹1,001, indicating a healthy, diversified consumer basket size.

Leadership

Key leadership mentioned includes:

  • Mr. B.L. Mittal (Executive Chairman, Managing Director, CEO, and Founding Member)
  • Mr. Ravi Kant Sharma (Non-Executive Director and Founding Member)
  • Mr. Pratap Singh (Company Secretary & Compliance Officer)

Other members of the leadership team are also listed with their roles and experience.